All News #Library
Sciences
Plus Therapeutics Advances CNSide CSF Tumor Test Reimbursement
07 Apr 2026 //
GLOBENEWSWIRE
Plus Therapeutics Secures Highmark Coverage for CNSide Assay
02 Apr 2026 //
GLOBENEWSWIRE
Plus Therapeutics Secures Unitedhealthcare Deal For CNside®
25 Sep 2025 //
GLOBENEWSWIRE
Plus Therapeutics Secures CNSide® Diagnostics Lab Accreditation
18 Sep 2025 //
GLOBENEWSWIRE
Plus Therapeutics Announces Leadership for CNSide Diagnostics
24 Feb 2025 //
GLOBENEWSWIRE
Plus Presents Positive FORESEE Trial Summary on CNSide™ Assay
22 Nov 2024 //
GLOBENEWSWIRE
Plus Therapeutics to CNSide Assay Data in Leptomeningeal Metastases
21 Nov 2024 //
GLOBENEWSWIRE
Plus Therapeutics Completes Sixth Dosing Cohort in ReSPECT™ Glioblastoma Trial
15 Dec 2020 //
GLOBENEWSWIRE

Market Place
Sourcing Support